Athenese-Dx Private Limited

Athenese-Dx Private Limited - healthcare in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U85100TN2012PTC084632 Incorporated 24 February 2012 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2024
₹73.45 Cr
▲ 1% YoY
Net profit · FY 2024
₹4.26 Cr
Net margin 5.8%
EBITDA · FY 2024
₹6.74 Cr
EBITDA margin 9.2%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹70.16 Lakh
Issued & subscribed
Satisfied charges
₹50 Lakh
No open charges
Company age
14 yrs
Est. 2012
Employees · EPFO
289
Provident fund records

About Athenese-Dx Private Limited

Data last updated:

Athenese-Dx Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 24 February 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U85100TN2012PTC084632. Its GSTIN is 07AAKCA4573B1ZU (Delhi).

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹70.16 Lakh. It is led by directors including Arunkumar Chakravarthy (Whole-Time Director) and Catherine Yaping Chen.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Module No.407 & 408 4th Floor Ticel Bio Park II No.5 Csir Road Taramani, Chennai, Tamil Nadu, India – 600113.

As per the financials filed for FY 2024, the company reported a revenue of ₹73.45 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹4.26 Cr (net margin 5.8%) and EBITDA of ₹6.74 Cr (EBITDA margin 9.2%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 15% over five years.

The company has about 289 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Athenese-Dx. As per MCA filings, the company has satisfied charges of ₹50 Lakh on record. Court records list 29 cases involving the company, including 24 filed by the company and 5 filed against it; 4 cases are pending. The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹4.06 Cr; the latest was in September 2023. Its 10 peer companies in the Healthcare industry (Medical and Laboratory Equipment) are compared by revenue, 5 larger and 5 smaller; the largest is Genuine Medica Private Limited with revenue of ₹76.22 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 847 overdue payments to 74 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website athenesedx.com.

Company Details of Athenese-Dx Private Limited
CIN U85100TN2012PTC084632
Registration Number 084632
Incorporation Date 24 February 2012
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Arunkumar Chakravarthy Whole-Time Director Catherine Yaping Chen Director Srikrishnan Additional Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    athenesedx.com
  • Social Media
  • Registered Address
    Module No.407 & 408 4th Floor Ticel Bio Park II No.5 Csir Road Taramani, Chennai, Tamil Nadu, India – 600113
  • Industry
    Healthcare, Medical & Laboratory Equipment
Comprehensive company report
Athenese-Dx Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Athenese-Dx Private Limited report

Financials, compliance, directors, charges, ownership and filings for Athenese-Dx Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Athenese-Dx Private Limited

The main business activities of Athenese-Dx are trade, manufacturing and support service to organizations. In detail, this covers wholesale trading, other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities and other support services to organizations. 3 activity segments are registered with the MCA.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
CManufacturingC13Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activitiesLocked
NSupport service to OrganizationsN7Other support services to organizationsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Athenese-Dx Private Limited FY 2025 filings available

Athenese-Dx Private Limited reported revenue of ₹73.45 Cr (up 1% YoY) for FY 2024.

Revenue · FY 2024
₹73.45 Cr ▲ 1%
Net profit · FY 2024
₹4.26 Cr margin 5.8%
EBITDA · FY 2024
₹6.74 Cr margin 9.2%

Compounded Annual Growth Rate (CAGR) of Athenese-Dx Private Limited

Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 12%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 3%
5 years · compounded
▲ 15%

Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 1% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Athenese-Dx Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹6.74 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹4.26 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Athenese-Dx Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin9.2%••••••••••••••••
Net Profit Margin5.8%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Athenese-Dx are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Athenese-Dx Private Limited

Athenese-Dx Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Genuine Medica Private Limited₹76.22 Cr (FY 2025)••••••••45.0%••••New Delhi, Delhi, India
Hilsun Pharma Private Limited₹74.42 Cr (FY 2025)••••••••27.0%••••Delhi, India
Casid Pharmaceuticals Private Limited₹74.41 Cr (FY 2025)••••••••28.0%••••Manachanalloor, Tamil Nadu, India
Shreeji Imaging and Diagnostic Centre Private Limited₹73.82 Cr (FY 2024)••••••••11.0%••••Mumbai, Maharashtra, India
Hicks Thermometers India Limited₹73.62 Cr (FY 2025)••••••••19.0%••••Uttar Pradesh, India
Athenese-Dx Private Limited this company₹73.45 Cr (FY 2024)••••••••1.0%••••Chennai, Tamil Nadu, India
Bamc Medical Limited₹73.13 Cr (FY 2025)••••••••166.0%••••Panipat, Haryana, India
Thermolab Scientific Equipments Private Limited₹73.1 Cr (FY 2024)••••••••18.0%••••Vasai, Maharashtra, India
Phoenix Medical Systems Private Limited₹72.93 Cr (FY 2024)••••••••-19.0%••••Chennai, Tamil Nadu, India
Ausa Medical Devices Private Limited₹72.63 Cr (FY 2024)••••••••35.0%••••Bengaluru, Karnataka, India
Nucrest Pharma Private Limited₹71.97 Cr (FY 2025)••••••••21.0%••••Mumbai, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Athenese-Dx by revenue in the Healthcare industry (Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Athenese-Dx Private Limited

Athenese-Dx Private Limited is audited by S.M.MANI BHURAT for the financial year 2023.

NameStatusAppointment DateCessation Date
S.M.MANI BHURATLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Athenese-Dx Private Limited

Athenese-Dx has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Arunkumar ChakravarthyWhole-Time Director06 Jan 20179 Years 9 MonthsCurrent
Catherine Yaping ChenDirector30 Dec 20205 Years 9 MonthsCurrent
SrikrishnanAdditional Director14 Nov 20250 Years 10 MonthsCurrent
View all directors

Ownership and Shareholding of Athenese-Dx Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Athenese-Dx Private Limited

Open charges
None
Satisfied charges
₹50 Lakh
Breakdown by lending institutions
Sidbi₹0.50 Cr
Latest charge details
DateLenderAmountStatus
28 May 2020Sidbi₹50 LakhSatisfied

Total charge records: 1 View all charges

Deals & Funding of Athenese-Dx Private Limited

Athenese-Dx Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹4.06 Cr; the latest was in September 2023.

Total deals
6
Secondary share transfers
4
Funding rounds
2
Disclosed funding
₹4.06 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Sep 2023Funding round₹1.31 CrInvestors: Athenese Inc
Jul 2021Funding round₹2.75 CrInvestors: Athenese Inc
Mar 2021Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2018Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Feb 2014Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Premium access

Full deal history

All 6 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME Payment Delays by Athenese-Dx Private Limited

Athenese-Dx Private Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 847 overdue payments to 74 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 74)

SupplierAmount dueDue sinceReported on
Sai Sakthi Printers••••••••••••
Desiccants India LLP••••••••••••
an individual supplier••••••••••••
Sanguine Logistics Private Limited••••••••••••
an individual supplier••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 14 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Associated Brands with Athenese-Dx Private Limited

Athenese-Dx operates one associated brand: Athenese-Dx. Each brand links to its own profile.

BrandDescriptionWebsite
Athenese-Dx
Develops, manufactures, and markets in vitro diagnostic tests and instruments for healthcare.athenesedx.com

Employees and EPFO Compliance at Athenese-Dx Private Limited

Athenese-Dx Private Limited has a workforce of 289 employees as of May 11, 2024.

Employee count
289
Active EPFO establishments
1
Employee growth
-0.34%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Athenese-Dx Private Limited

Athenese-Dx Private Limited has 11 board changes on record since 2014: 4 appointments and 7 cessations. The latest: Srikrishnan was appointed as Additional Director on 14 Nov 2025.

Appointed
Srikrishnan was appointed as Additional Director.
AGM
Athenese-Dx Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Athenese-Dx Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge registered on 28 May 2020 via Charge ID 100338474 with Sidbi was fully satisfied on 04 May 2022.
Appointed
Catherine Yaping Chen was appointed as Director.
Ceased
Selvaraju Govindasamy ceased to be Additional Director.
Ceased
Bala Pandi ceased to be Director.
Appointed
Selvaraju Govindasamy was appointed as Director.
Charges
A charge with Sidbi amounted to Rs. 0.50 Cr with Charge ID 100338474 was registered on 28 May 2020.
Ceased
Tamilmani Elavarasan ceased to be Additional Director.
Ceased
Catherine Yaping Chen ceased to be Director.
Ceased
Arunkumar Chakravarthy ceased to be Additional Director.

4 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Athenese-Dx Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Athenese-Dx Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Athenese-Dx Private Limited

Athenese-Dx has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAKCA4573B1ZUDelhiActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Athenese-Dx Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Athenese-Dx Private Limited

Athenese-Dx is an active private limited company based in Chennai, Tamil Nadu, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 24 February 2012 (14+ years old) and is registered under CIN U85100TN2012PTC084632.

Athenese-Dx reported revenue of ₹73.45 Cr for FY 2024 (up 1% YoY).

Athenese-Dx has 3 current directors:

Athenese-Dx reported a net profit of ₹4.26 Cr (net margin 5.8%) and EBITDA of ₹6.74 Cr (EBITDA margin 9.2%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Athenese-Dx is 12% over three years and 15% over five years. In the latest year (FY 2024) revenue rose 1%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Athenese-Dx is 07AAKCA4573B1ZU, registered in Delhi.

The CIN (Corporate Identification Number) of Athenese-Dx is U85100TN2012PTC084632. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Athenese-Dx has 29 court cases on record: 24 filed by the company and 5 filed against it. 4 are pending. Most are in the district courts.

Athenese-Dx was incorporated on 24 February 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chennai.

Athenese-Dx has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹4.06 Cr; the latest was in September 2023.

The peers of Athenese-Dx by revenue are Genuine Medica Private Limited, Hilsun Pharma Private Limited, Casid Pharmaceuticals Private Limited, Shreeji Imaging and Diagnostic Centre Private Limited, Hicks Thermometers India Limited and 5 more, all in the Healthcare industry (Medical and Laboratory Equipment).

Srikrishnan was appointed as Additional Director on 14 Nov 2025. Catherine Yaping Chen was appointed as Director on 30 Dec 2020. Selvaraju Govindasamy ceased to be Additional Director on 30 Dec 2020. Athenese-Dx has 11 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available